Charity number: 326971
THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
UNAUDITED
TRUSTEES. REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
CONTENTS
Page
Reference and administrative details of the Charity, its Trustees and advisers
Trustees, report
Independent examiner's report
Statement of financial activities
Balance sheet
Notes to the financial statements
8-15

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS
FOR THE YEAR ENDED 31 JULY 2024
Trustees
Prof R M Greenhalgh MA MD Mchir FRCS {deceased 6 October 2023)
S Greenhalgh
N B Botterill
N Bence-Trower
Charity registered
number
326971
Principal office
528 Fulham Road
London
SW6 5NR
Independent Examiner
lan Saunderson FCA
BKL Audit LLP
35 Ballards Lane
London
N3 1XW
Investment Advisers
Cazenove Capit81 Management
12 Moorgate
London
EC2R 6DA
Sollcitors
SMR Solicitors
50 Westgate
Chichester
West Sussex
P019 3HE
Page 1

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
TRUSTEES. REPORT
FOR THE YEAR ENDED 31 JULY 2024
The Trustees present their annual report together with the financial statements of the Charity for the year 1
August 2023 to 31 July 2024.
Objectives and actlvltles
a. Policies and objectlves
The principal object of the Foundation is to promote the relief of sickness of persons who suffer or are likely to
suffer from vascular disease. This object has been achieved by making grants, particularly to Imperial College
School of Medicine.
In setting objectives and planning for activities, the Trustees have given due Consideration to general guidance
published by the Charity Commission relating to public benefrt, including the guidance 'Public benefrt- running a
charity (P82)'.
b. Activities undertaken to achieve objectives
The Charity undertakes to give grants to worthy organisations in order to achieve it's objectives.
c. Main activities undertaken to further the Charity's purposes forthe publlc benefit
The charity has continued to successfully fund medical research that has completed studies and published
articles on rupture rates of small abdominal aortic aneurysm as well as on the rare and predictability of graft
rupture after endovascular and open abdominal aortic aneurysm repair.
The work carried out in previous years through funding by the Foundation on three4imensional imaging of scans
for aortic aneurysm was successfully published in the European Journal of Vascular and Endovascular Surgery.
The policy remained to take out only seed money and not to fund major research efforts.
The Charity has not been able to make significant grants within the financial year. The Charity plans to resume
grant funding in the near future.
Achievements and performance
a. Investment Perfomianco
The investment portfolio has been managed during the year under review by our Investment Advisors in
accordance with the discretionary pcwers given to them. The market value of the Foundation's investments
decreased during the year due to slightly faltering market conditions.
b. Investment Powers
The Trustees are authorised to make and hold investments using the general funds of the Charity. The
investments made are upon the advice of the Charty's investrnent advisors, Cazenove Capital Management.
Flnanclal review
a. Going concern
After making appropriate enquiries, the Trustees have a reasonable exp8Ctation that the Charity has adequate
resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt
the going concern basis in preparing the financial statements. Further details regarding the adoption of the going
concern basis can be found in the accounting policies.
Page 2

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
TRUSTEES. REPORT {CONTINUED)
FOR THE YEAR ENDED 31 JULY 2024
b. Reserves pollcy
The Trustees, policy for investment is to maximise the total return. The policy has been followed during the year
under the review. The Trustees aim to maintain reserves of £1 million to preserve the continuty of the
Foundation for the foreseeable future.
The current policy and level of investments is considered. by the Trustees, as appropriate to facilitate anticipated
outgoing grant funding.
c. Review of the Year
During the Year the Charity generated income of £74,302 (2023.. £68,379) entirety from investments.
Expenditure amounted to £3,997 (2023.. £9,630), being £1,857 {2023'. £6,090) on raising funds and £2,140
(2023: £3,540) on charitable activities. There was a profft on investment revaluation of £142,387 (2023- Loss of
£31,055). The Charity made a surplus of £212,692 (2023: surplus of £27,694) to give funds carried forward at
the year end of £1,844,176 {2023: £1,631,484). All income, expenditure, losses on investment revaluations and
funds are unrestricted in nature.
Structure, governance and management
a. Constitution
The Camelia Bortnar Arterial Research Foundation (formerly known as The AFG Arterial Disease Research
Foundation) was constituted by the means of a Declaration of Trust dated 25th September 1985. The deed was
subsequently updated on 23rd August 1996 (changing the name of the Foundation) and 16th June 2009.
b. Methods of appointment or electlon of Trustees
New Trustees are recruited when required from those who are interested in and connected to research work that
the Foundation supports. They meet annually to approve grant applications.
No Trustee received any renumeration or expenses in respect of services to the Foundation.
Page 3

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
TRUSTEES, REPORT (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2024
Statement of Trustees. responsibilities
The Trustees are responsible for preparing the Trustees. report and the financial statements in accordance wth
applicable law and Unrted Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting
Practice).
The law applicable to charities in England & Wale5 requires the Trustees to prepare financial statements for
each financial which give a true and fair view of the state of affairs of the Charty and of its incoming resources
and application of resources, including its income and expenditure, for that period. In preparing these financial
statements, the Trustees are required to:
select suitable accounting policies and then apply them consistently;
observe the methods and principles of the Charities SORP (FRS 102).
make judgments and accounting estimates that are reasonable and prudent,.
state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material
departures disclosed and explained in the financial ststements.,
prepare the financial statemenls on the going con￿rn basis unless it is inappropriate to presume that the
Charity will continue in business.
The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain
the CharilYs transactions and disclose with reasonable accuracy at any time the financial position of the Charity
and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity
(Accounts and Reports) Regulations 2008 and the provisions of the Trust deed. They are also responsible for
safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of
fraud and other irregularities.
Approved by order of the members of the board of Trustees and signed on their behalf by.
reerfhalgh
Trustee
Date:
Page 4

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
INDEPENDENT EXAMINER'S REPORT
FOR THE YEAR ENDED 31 JULY 2024
Independent Examiner's Report to the Trustees of The Camella Botnar Artarial Research
Foundation ('the Charity,)
I report to the charity Trustees on my examination of the accounts of the Charity for the year ended 31 July 2024.
Responsibilities and Basis of Report
As the Trustees of the Charity you are responsible for the preparation of tha accounts in accordance with the
requirements of the Charities Acl 2011 ('the 2011 Acr).
I report in respect of my examination ofthe Charitys accounts carried out under section 145 of the 2011 Act and
in carrying out my examination I have followed the applicable Directions given by the Charity Commission under
section 145(5)(b) of the 2011 Acl.
Independent Examiner's Statement
I have completed my examination. l Confirm that no matters have come to my attention in connection wrth the
examination giving me cause to believe that in any material respect:
accounting records were not kept in respect of th8 Charity as required by Section 130 of the 2011 Act. or
the accounts do not accord with those records. or
the accounts do not comply with the applicable requirements concerning the form and content of
accounts set out in the Charities {Accounts and Reports) Regulations 2008 other than any requirement
that the accounts give a 'true and fairf view which is not a matter Considered as part of an independent
examination.
I have no concerns and have come across no other matters in connection with the examination to which
attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
This report is made solely to Ihe Charsws Trustees, as a body, in acurdance with Part 4 of the Charities
(Accounts and Reports) Regulation5 2008. My work has been undertaken so thal I might state to the Charitys
Trustees those matters l am required to state to them in an Independent examiner's report and for no other
purpose. To the fullest extent pennitted by law, I do not accept or assume responsibilily to anyone other than the
Charity and the Charity's Trustees as a body, for my work or for this report.
Signed:
Dated..
lan Saundetson FCA
BKL Audit LLP
35 Ballards Lane
London
N3 1XW
Page 5

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 31 JULY 2024
Unrestricted
funds
2024
Total
funds
2024
Total
funds
2023
Note
Income from:
Investments
74.302
74,302
68,379
Total income
74.302
74,302
68.379
Expenditure on:
Raising funds
Charitable activities
1.857
2.140
1,857
2,140
6,090
3,540
Total expenditure
3,997
3,997
9, 630
Net income before net gainsl(losses) on
investments
Net gainsl(losses) on investments
70,305
79,580
70,305
79,580
58, 749
(31,055)
Net movement in funds
149.885
149,885
27,694
Reconciliation of funds:
Total funds brought forward
Net movement in funds
1,631,484
149,885
1,631,484
149,885
1,603, 790
27,694
Total funds carried forward
1,781,369
1,781,369
1,631,484
The Statement of Financial Activities includes all gains and losses recognised in the year.
The notes on pages 8 to 15 fomi part of these financial statements.
Page 6

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
BALANCE SHEET
AS AT 31 JULY 2024
2024
2023
Note
Fixed assets
Investments
1.492,994
1,417,877
1A92,994
1,417,877
Current assets
Debtors
Cash at bank and in hand
10
15,664
274.851
15,805
203,037
290.515
218,842
Creditors.. amounts falling due within one
year
{2,140>
(5,235)
Net current assets
288,375
213,607
Totsl net assets
1,781,369
1,63q,484
Charity funds
Unrestricted funds
12
1.781.369
1.631,484
Total funds
1,781,369
1, 631,484
The financial statements were approved and authorised for issue by the Trustees and signed on their behalF by=
re
Trustee
Date:
The notes on pages 8 to 15 fonn part of these financial statements.
Page 7

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024
Accountlng policies
1.1 Basis of preparation of financial statements
The financial statements have been prepared in accordance with the Charities SORP (FRS 102> -
Accounting and Reporting by Charities.. Statement of Recommended Practice applicable to charilies
preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK
and Republic of Ireland (FRS 102) {eff8Ctive 1 January 2019), the Financial Reporting Stsndard
applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011.
The Camelia Botnar Arterial Research Foundation meels the definition of a public benefrt entty under
FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless
otherwise stated in the relevant accounting policy.
1.2 Going concern
The Charity has minimal fixed costs, with the main source of expenditure being grants made to
institutions which can be made at the discretion of the Trustees. Furthermore, the Charity had a
heatthy cash balance at the year end. After making approprTate enquiries, the Truslees therefore
have a reasonable expectation that the Charity has adequate resources to continue in operational
existence for the foreseeable future. For this reason, they continue to adopt the going concem basis
in preparing the financial statements.
1.3 Income
All income is recognised once the Charty has entitlem8nt to the income, it is probable that the
income will be received and the amount of income receivable can be measured reliably.
Income tax recoverable in relation to investment income is recognised at the time the investment
income is receivable.
1.4 Expondituro
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefft
to a third party, it is probable that a transfer of economic benefits will be required in settlement and
the amount of the obligation can be measured reliably.
Expenditure on raising funds includes all expenditure incurred by the Charity to raise funds for its
charrtable purposes and includes costs of all fundraising activities events and non<haritable trading.
Expenditure on charitable actwities is incurred on directly undertaking the activities which further the
Charity's objectives, as well as any associated support costs.
Grants payable are charged in the year when the offer is made except in those cases where the offer
is conditional, such grants being recognised as expenditure when the conditions attaching are
fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a
commitm8nt, but not accrued as expenditure.
All expenditure is inclusive of irrecoverable VAT.
Page 8

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024
Accounting pollciès {continued)
1.5 Int•rest receivable
Interest on funds held on deposit is included when receivable and the amount can be measured
reliably by the Charity; this is normally upon notification of the interest paid or payable by the
institution with whom the funds are deposited.
1.6 Investments
Fixed asset investments are a fomi of financial instrument and are initially recognised at their
transaction cost and subsequently measured at fair value at the Balance Sheet date, unless Ihe value
cannot be measured reliably in which case rt is measured at cost less impairment. Investment gains
and losses, whether realised or unrealised, are combined and presentèd as 'Gainsl{Losses) on
investments, in the Statement of financial activities.
1.7 Debtors
Trade and other debtors are recognised at the settlement amount after any trade discount offered.
Prepayrnents are valued at the amount prepaid net of any trade discounts due.
1.8 Cash at bank and in hand
Cash at bank and in hand includes cash and short-tem highly liquid investments with a short maturity
of thrte months or less from the date of acquisition or opening of the deposit or similar account.
1.9 Liabilities and provislons
Liabilities are recognised when there is an obligation at the Balance sheet date as a result of a past
event, it is probable that a transfer of economic benefit will be required in settlement. and the amount
of the settlement can be estimated reliably.
Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the
amount it has received as advanGed payments for the goods or services it must provide.
1.10 Fund accounting
General funds are unrestricted funds which are available for use at the discretion of the Trustees in
furtherance of the general objectives of the Charity and which have not been designated for other
putposes.
Investment income, gains and losses are allocated to the appropriate fund.
Page 9

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024
Investment income
Unrestricted
funds
2024
Total
funds
2024
Investment income
Bank interest
62,950
11,352
62,950
11,352
74,302
74,302
Unrestricted
funds
2023
Total
fvnds
2023
Investment income
Bank interest
63,042
5,337
63.042
5,337
68,379
68,379
Investment management costs
Unrestricted
funds
2024
Total
funds
2024
Portfolio management
1,857
1,857
Unrestricted
funds
2023
Total
funds
2023
Portfolio management
6,090
6, 090
Page 10

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024
Analysis of grants
Grants to
Individuals
2024
Total
funds
2024
Research of Vascular Disease
Grdnts to
Indiwduals
2023
Total
fvnds
2023
Research of Vascular Disease
1,500
Analysis of expenditure on charltable activities
Summary by fund type
Unrèstricted
funds
2024
Total
2024
Research of Vascular Diseasè
2,140
2,140
Unrestricted
funds
2023
Total
2023
Research of Vascular Disease
3, 540
3, 540
Page11

THE CAMELIA BOTNARARTERIAL RESEARCH FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024
Anatysls of expenditura by activitles
Support
costs
2024
Total
funds
2024
Research of Vascular Disease
2,140
2,140
Grant
funding ol
actwities
2023
Support
costs
2023
Total
funds
2023
Research of Vascular Disease
1,5QO
2,040
3, 540
Analysis of support costs
Research of
Vascular
Disease
2024
Total
funds
2024
Governance costs
2,140
2,140
Governan￿ costs consist entirely of fees payable to the Charitls Independent Examiner.
Resgarch ol
Vascular
Disease
2023
Total
funds
2023
Governance costs
2,040
2,040
Governance costs in the prior year consist entirely of fees payable to the Chariws Independent
Examiner.
Page 12

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024
Indapendent examinerfs r•muneration
2024
2023
Fees payable to the Chantys independent examiner for the preparation and
independent examination of the Charitys annual accounts
2,140
2,040
Trustees, remuneration and expenses
During the year, no Trustees re￿iVed any remuneration or other benefrts (2023- £NIL).
During the year ended 31 July 2024, no Trustee expenses have been incurred (2023- £NIL).
Fixed asset inveslmants
Listed
investments
Cost or valuation
At 1 August 2023
Disposals
Revaluations
1,417,877
(4.463)
79,580
At 31 July 2024
1,492,994
Net book value
At 31 July 2024
1.492,994
At 31 July 2023
1,417,877
10. Debtors
2024
2023
Due within one year
Prepayments and accrued income
15,664
75,805
15.664
15,805
Page 13

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024
11. Creditors: Amounts falling dua within one year
2024
2023
Accruals and deferred income
2.140
5, 235
12. Statsment of funds
ststement of funds - current year
Balance at 1
August 2023
Galnsl Balance at
(Losses) 31 Juty 2024
Income Expenditure
unrestrict￿ funds
General Funds - all funds
1,631A84
74,302
(3,997)
79,580
1,781,369
Statement of funds - prior year
Balance at
1 August
2022
Gains/
Balan￿ at
(Losses) 31 July 2023
Income Expenditure
Unrestricted funds
General Funds- all funds
1,603, 790
68,379
(9,630)
(3q,055) 1,631,484
13. Analysis of net assets between funds
Analysis of net assets between funds - current period
Unrestrlcted
funds
2024
Total
funds
2024
Fixed asset investments
Current assets
Creditors due within one year
1,492,994
290,515
(2.140)
1,492,994
290,515
{2,140)
Total
1,781,369
1,781.369
Page 14

THE CAMELIA BOTNAR ARTERIAL RESEARCH FOUNDATION
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024
13. Analysis of not assets between funds (contlnued)
Analysls of net assets between funds - prior perfod
UnTrstricted
funds
2023
Total
funds
2023
Fixed asset investments
Current assets
Creditors due within one year
1,417,877
218,842
(5,235)
1,417,877
218,842
(5,235)
Total
1, 631, 484
1, 631.484
14. Related party transactlons
There were no related party transactions during the year.
Page 15

Camelia Botnar Arterial Research
Foundation
526 Fulham Road, London. SW6 5NR
Date: .......-...-....
Your ref- C1941
BKL Audit LLP
35 Ballards Lane
London
N3 IXW
Dear Sirs
Camelia Botnar Arterlal Research Foundation
We confirm to the best of our knowledge and belief, and having made approprlate enquiries of other trustees
and officials of the Charity, the following representations in connection wlth your repcrt on the Charity's
financial ststements for the year ended 31 July 2024.
We acknowledge that the work performed by you is substantially less in scope than an audit performed
in accordance with Auditin8 Standards and that you do not express an audit opinion.
We confirm that the Charity was entitled to exemption from the requirement to have its financial
ststements for the financial year audited.
We have fulfilled as trustees our responsibility for the financial statements which give a true and fair
view in accordance with the requirements of the Charities Act 2011 and which otherwise comply with
the requirements of that Act relating to financial statements, so far as applicable to the Charity. All the
accounting records have been made available to you and all transactions undertaken by the Charity have
been properly reflected in those accounting record5. All records and related information. including the
minutes of the trustee5' and rnembers, meetings have been made availablè to you.
We confirm that we have maintained proper accounting records, as required by the Charities Act 2011.
We confirm, to the best of our knowledge and belief. that there have been no instances of non-
compliance or breaches of any laws or regulations which are essential to the activities of the ChariWs
attivities.
We confirm that assets are included on the balance sheet at no more than their recoverable amounts
and that liabilities are included at their expected c05t to the Charity,
Reglstered charlty no. 326971

We confirm that we are not aware of any pendin8 litigation which may result in a significant loss to the
Charity.
We confirm that there were no contingent liabilities at the balance sheet date.
We believe that the Charity's financial ststements Should be prepared on a going concern basis on the
ground5 that current and future sources of funding and support will be more than adequate for the
Charity's needs. We have considered a period of twelve month5 from the date of approval of the
financial statements. We believe that no further disclosures relating to the Charity's ability to continue
as a going concem need to be made in the financial statements.
io.
We confirm that there were no transactions with related parties of the Charity or amounts due to or
from related parties at the balance sheet date which are required to be disclosed in the financial
statements other than those which are detailed in the notes to the financial statements.
ii.
We confirm that there have been no events since the balance sheet date which necessitate revision of
the figures included in the financial Statements or disclosure in the notes to the financial statements.
Should further material events occur, which may necessitate revision of the figure5 included in the
financial statements or inclusion of a note thereto, we will advise you accordingly.
Yours faithfullv
SiBned on behalf of the Board of Trustees
Camelia Botnar Arterial Research Foundation
PAGE20F2